Der Vortrag „Quick Review: Rheumatoid Arthritis“ von Stephen Holt, MD, MS ist Bestandteil des Kurses „Year 3 – Internal Medicine“.
Which of the following is considered to be a first-line disease-modifying anti-rheumatic drug (DMARD) for rheumatoid arthritis?
5 Sterne |
|
5 |
4 Sterne |
|
0 |
3 Sterne |
|
0 |
2 Sterne |
|
0 |
1 Stern |
|
0 |